purpos
studi
evalu
use
highresolut
comput
tomographi
hrct
differenti
smearposit
activ
pulmonari
tuberculosi
ptb
pulmonari
infect
emerg
room
er
set
method
one
hundr
eightythre
patient
diagnos
pulmonari
infect
er
divid
acid
fast
bacillu
afb
smearposit
activ
ptb
group
nonafb
smearposit
pulmonari
infect
group
hrct
imag
ct
analyz
retrospect
morpholog
number
segment
distribut
pulmonari
lesion
result
util
multivari
analysi
five
variabl
found
independ
risk
factor
predict
consolid
involv
apex
segment
right
upper
lobe
posterior
segment
right
upper
lobe
apicoposterior
segment
left
upper
lobe
consolid
involv
superior
segment
right
left
lower
lobe
presenc
cavitari
lesion
presenc
cluster
nodul
absenc
centrilobular
nodul
predict
score
gener
base
criteria
help
differenti
area
receiv
oper
characterist
roc
curv
predict
model
ideal
cutoff
point
score
specif
sensit
posit
predict
valu
ppv
neg
predict
valu
npv
respect
conclus
use
afb
smearposit
activ
ptb
predict
model
base
key
hrct
find
may
help
er
physician
determin
whether
isol
requir
await
serial
sputum
smear
result
high
risk
patient
infect
mycobacterium
tuberculosi
current
affect
nearli
onethird
world
popul
highli
contagi
pulmonari
tuberculosi
ptb
masquerad
communityacquir
pneumonia
cap
escap
initi
diagnosi
emerg
room
er
physician
therebi
increas
risk
nosocomi
infect
transmiss
gener
popul
current
screen
method
recommend
center
diseas
control
prevent
cdc
involv
respiratori
isol
ri
suspect
ptb
patient
sputum
sampl
obtain
h
neg
expand
ri
polici
patient
suspect
ptb
unit
state
led
proper
isol
ptb
upon
admiss
howev
also
result
overus
isol
room
eventu
led
insuffici
number
isol
room
threaten
acut
lung
diseas
sever
acut
respiratori
syndrom
sar
viru
new
influenza
nowaday
isol
polici
wait
time
smear
result
patient
mere
suspect
activ
ptb
may
prove
burdensom
hospit
furthermor
isol
polici
base
sole
upon
neg
sputum
sampl
may
adequ
account
truli
posit
sputum
miss
due
low
organ
load
therefor
effect
diagnost
test
andor
criteria
differenti
patient
highest
risk
activ
ptb
desper
need
highresolut
comput
tomographi
hrct
shown
effect
differenti
diagnosi
acut
parenchym
lung
diseas
chest
radiograph
cxr
hrct
indic
find
suggest
pneumonia
almost
day
earlier
cxr
recent
ito
et
al
use
hrct
differenti
bacteri
cap
nonbacteri
cap
although
sever
predict
model
diagnosi
activ
ptb
propos
recent
year
none
specif
focus
diagnosi
smearposit
activ
ptb
hrct
object
studi
investig
propos
triag
protocol
use
hrct
initi
ri
patient
afb
smear
posit
ptb
er
sputum
smear
result
known
ultim
intent
reduc
spatial
financi
burden
hospit
minim
addit
risk
patient
healthcar
worker
juli
march
retrospect
studi
perform
patient
evalu
er
pingtung
christian
hospit
teach
hospit
pingtung
taiwan
identifi
pulmonari
symptom
initi
inclus
criteria
presenc
infiltr
cxr
symptom
suggest
cap
cap
defin
presenc
acut
ill
day
less
durat
one
symptom
fever
confus
sweat
ach
etc
least
two
new
increas
cough
sputum
product
short
breath
wheez
new
focal
diffus
sign
physic
examin
cxr
consist
infect
neither
preexist
known
caus
treatment
antibiot
pneumonia
pulmonologist
infect
clinician
patient
treat
er
physician
follow
either
pulmonologist
infecti
diseas
specialist
patient
pulmonari
infiltr
select
analysi
exclud
patient
refus
particip
studi
lost
followup
major
patient
also
exclud
studi
variou
reason
hiv
infect
n
hospit
within
day
er
present
n
hrct
studi
n
presenc
tumor
n
presenc
underli
diseas
collagen
vascular
diseas
coinfect
n
requir
hospit
n
isol
home
symptom
sign
mild
antitb
drug
toler
remain
patient
suspect
cap
ptb
receiv
hrct
studi
enrol
studi
regular
sampl
includ
least
sputum
specimen
blood
cultur
pair
serolog
specimen
admiss
within
week
thereaft
addit
diagnost
techniqu
util
includ
pleural
punctur
transbronchi
aspir
flexibl
bronchoscopi
protect
specimen
brush
urin
sampl
legionella
speci
antigen
sputum
sampl
gram
stain
sputum
appropri
analysi
origin
lower
respiratori
tract
defin
contain
least
granulocyt
less
epitheli
cell
per
lowpow
field
valid
sputum
sampl
blood
cultur
sampl
pleural
fluid
protect
specimen
brush
sampl
plate
sheep
blood
agar
microorgan
identif
perform
accord
standard
protocol
patient
assign
group
accord
sputum
cultur
result
afb
sputum
smear
posit
activ
ptb
n
includ
patient
least
one
posit
sputum
smear
posit
cultur
mycobacterium
tuberculosi
group
remain
patient
neg
sputum
smear
cultur
mycobacterium
tuberculosi
group
subdivid
addit
group
group
includ
patient
afbsmear
neg
activ
ptb
base
upon
least
three
neg
sputum
smear
posit
cultur
group
includ
patient
inact
ptb
base
upon
find
residu
fibrot
chang
cxr
absenc
diseas
progress
cxr
recruit
compar
month
previous
followup
absenc
afb
sputum
bronchial
wash
smear
cultur
group
includ
patient
without
evid
ptb
definit
pathogen
identifi
isol
pneumococcu
pneumonia
klebsiella
pneumonia
hemophilu
influenza
cultur
blood
pleural
effus
atyp
pneumonia
bacteri
pneumonia
legionella
pneumophila
mycoplasma
pneumonia
caus
rise
antibodi
titer
serolog
test
lung
biopsi
wedg
section
prove
presenc
herp
simplex
viru
actinomycosi
aspergillosi
patient
follow
characterist
recommend
process
hrct
age
complic
cap
interstiti
lung
diseas
tumor
suspect
hrct
morpholog
pattern
ptb
describ
fig
chest
ct
scan
without
contrast
media
mm
collim
kv
tabl
speed
mm
rotat
time
pitch
use
scanner
brillianc
philip
medic
system
cleveland
oh
usa
perform
patient
imag
acquir
singl
breathhold
long
make
respiratori
motion
artifact
uncommon
imag
reconstruct
slice
thick
axial
plane
gap
coron
plane
apart
use
high
spatialfrequ
algorithm
sent
pac
review
thinsect
mdct
imag
display
monitor
pulmonari
window
level
set
level
hu
width
hu
hrct
scan
evalu
two
radiologist
chest
physician
specialist
year
experi
read
thorac
radiolog
studi
unawar
sputum
smear
clinic
examin
result
find
reach
consensu
hrct
scan
assess
presenc
distribut
parenchyma
abnorm
locat
lung
involv
report
one
design
segment
lung
statist
analys
perform
use
spss
statist
softwar
spss
inc
chicago
il
usa
data
present
mean
standard
deviat
sd
continu
data
age
lag
time
tb
smear
lag
time
tb
cultur
number
percentag
use
categor
data
group
twosampl
ttest
use
compar
differ
group
continu
data
pearson
chisquar
test
fisher
exact
test
use
compar
differ
distribut
categor
data
group
furthermor
multipl
logist
regress
model
perform
indic
predictor
subject
smearposit
activ
ptb
estim
beta
standard
error
std
err
odd
ratio
confid
interv
histolog
specimen
biopsi
right
upper
lobe
via
videoassist
thoracoscopi
h
e
stain
photomicrograph
show
concentr
granuloma
center
nodul
cluster
granulomat
inflamm
peribronchoarteri
distribut
c
white
arrow
small
granulomata
c
white
arrowhead
peripheri
larg
nodul
e
histolog
specimen
biopsi
right
upper
lobe
via
videoassist
thoracoscopi
h
e
stain
photomicrograph
show
larg
tubercul
nodul
c
white
arrow
produc
numer
small
nodul
small
granulomata
c
white
arrowhead
peripheri
larg
nodul
peripher
low
attenu
spot
hrct
correspond
space
partial
coalesc
small
nodul
c
cluster
nodul
b
bronchu
arteri
ci
present
multivari
logist
regress
model
tabl
addit
rel
score
given
use
base
accord
studi
kanaya
et
al
rel
score
given
rel
ratio
area
receiv
oper
characterist
roc
curv
shown
indic
best
cutoff
point
fig
statist
analys
consid
signific
p
particip
studi
gave
written
consent
fulli
inform
studi
approv
ethic
review
board
institut
total
subject
receiv
hrct
analysi
includ
evalu
subject
classifi
group
afb
sputum
smear
posit
activ
ptb
n
group
sputum
smear
neg
pulmonari
infect
patient
n
tabl
present
demograph
data
method
confirm
smearposit
ptb
nonafb
smearposit
pulmonari
infect
patient
group
subgroup
signific
age
differ
group
male
compris
major
studi
group
comorbid
condit
anemia
diabet
alcohol
chronic
steroid
use
uremia
hypoalbuminemia
note
studi
patient
howev
presenc
anemia
prove
statist
signific
find
among
afb
sputum
posit
activ
ptb
group
histori
previou
ptb
signific
find
among
neg
sputum
smear
group
gener
spontan
sputum
examin
p
greater
percentag
group
patient
requir
bronchoscopi
sputum
examin
p
hrct
perform
patient
within
h
present
er
result
describ
tabl
hrct
pattern
like
ground
glass
opac
consolid
bronchial
wall
thicken
cluster
nodul
paratrach
adenopathi
interlobular
septal
thicken
cavit
frequent
p
meanwhil
hrct
pattern
calcif
fibrosi
frequent
p
statist
signific
differ
centrilobular
nodul
treeinbud
p
p
respect
anatom
distribut
number
lung
segmentssubseg
consolid
cavit
cluster
nodul
describ
tabl
consolid
involv
apex
segment
posterior
segment
right
upper
lobe
apicoposterior
segment
left
upper
lobe
consolid
involv
superior
segment
right
left
lower
lobe
cavit
apex
segment
posterior
segment
right
upper
lobe
apicoposterior
segment
left
upper
lobe
number
cavit
number
consolid
number
cluster
nodul
frequent
p
multivari
analysi
consolid
apex
segment
posterior
segment
right
upper
lobe
apicoposterior
segment
left
upper
lobe
p
consolid
superior
segment
either
lower
lobe
anatom
distribut
involv
segmentssubseg
number
segment
consolid
cavit
cluster
nodul
n
p
cavit
p
cluster
nodul
p
relat
number
locat
independ
signific
factor
predict
centrilobular
nodul
independ
neg
predict
valu
p
tabl
use
five
independ
variabl
associ
predict
score
gener
help
differenti
roc
curv
analysi
shown
fig
area
curv
predict
model
ideal
cutoff
point
score
specif
sensit
posit
predict
valu
ppv
neg
predict
valu
npv
respect
cluster
nodul
repres
peribronchovascular
nodul
signific
find
poey
et
al
heo
et
al
found
similar
result
among
patient
activ
ptb
studi
cluster
nodul
identifi
patient
compar
tanaka
et
al
studi
reveal
abbrevi
apic
segment
posterior
segment
right
upper
lobe
apicoposterior
segment
left
upper
lobe
superior
segment
right
left
lower
lobe
weight
score
observ
accord
ratio
estim
use
estim
cavit
base
rel
score
given
ratio
ratio
ratio
sinc
effect
centrilobular
nodul
neg
ratio
rel
score
set
pvalu
nodul
hrct
examin
cap
patient
activ
ptb
case
physician
er
play
crucial
role
identif
potenti
ptb
patient
hsieh
et
al
reveal
high
proport
hospit
activ
ptb
case
often
admit
erwith
initi
diagnosi
cap
delay
ri
increas
risk
nosocomi
infect
furthermor
activ
ptb
case
atyp
cxr
present
sputum
spontan
cough
steen
report
smearposit
ptb
patient
also
one
neg
initi
sputum
smear
divers
clinic
present
er
patient
ptb
well
limit
number
isol
room
avail
especi
influenza
outbreak
complic
triag
also
make
develop
implement
effect
triag
screen
criteria
crucial
success
ptb
manag
reduc
number
isol
patient
low
likelihood
activ
ptb
may
reduc
hospit
cost
import
misdiagnos
patient
smearposit
ptb
subsequ
cost
associ
late
treatment
contact
investig
could
actual
offset
origin
save
flu
season
influenza
one
lead
caus
er
visit
avail
isol
room
essenti
mind
creat
predict
score
base
key
hrct
find
consolid
involv
apex
segment
either
lung
posterior
segment
right
upper
lobe
apicoposterior
segment
left
upper
lobe
consolid
involv
superior
segment
right
left
lower
lobe
presenc
cavitari
lesion
presenc
cluster
nodul
absenc
centrilobular
nodul
roc
curv
fig
identifi
score
point
cutoff
point
sensit
hit
npv
approach
ideal
test
would
sensit
avoid
miss
patient
activ
diseas
npv
assur
neg
result
truli
repres
diseasefre
statu
extrem
import
public
health
situat
deal
highli
infecti
diseas
like
afb
sputum
posit
activ
ptb
campo
et
al
evalu
efficaci
singl
firstsputum
nucleic
acid
amplif
naa
test
rapidli
accur
identifi
subset
patient
suspect
tb
requir
isol
compar
serial
sputum
smear
analysi
current
endors
cdc
first
sputum
naa
demonstr
sensit
npv
studi
futur
diagnost
test
may
soon
includ
use
first
sputum
naa
current
guidelin
still
effect
furthermor
sputum
avail
spontan
cough
specimen
bronchoscop
naa
test
feasibl
studi
demonstr
effect
use
hrct
predict
smearposit
activ
ptb
case
advanc
serial
sputum
result
patient
without
spontan
sputum
therebi
decreas
transmiss
rate
open
isol
room
need
communic
diseas
influenza
sar
limit
scope
reliabl
reproduc
five
variabl
predict
ptb
demograph
clinic
characterist
patient
ptb
may
differ
geograph
area
model
need
valid
set
implement
clinic
practic
although
hrct
wide
avail
today
countri
may
access
hrct
technolog
reader
experi
anoth
limit
also
smearposit
activ
ptb
predict
model
base
upon
five
characterist
hrct
find
may
eas
burden
ri
area
avail
financi
resourc
limit
